Correction to: A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —AstraZeneca10.13039/100004325
- —DAN, TFC, BME
- —NIH10.13039/100000002
- —NCI10.13039/100000054
- —U.S. Department of Defense10.13039/100000005
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRadiomics and Machine Learning in Medical Imaging · Glioma Diagnosis and Treatment · Medical Imaging Techniques and Applications
This is a correction to: Benjamin M Ellingson, Quincy Okobi, Robert Chong, Rhea Plawat, Eva Zhao, Andrei Gafita, Ida Sonni, Saewon Chun, Emese Filka, Jingwen Yao, Donatello Telesca, Shanpeng Li, Gang Li, Albert Lai, Phioanh Nghiemphu, Johannes Czernin, David A Nathanson, Timothy F Cloughesy, A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma, Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf022, https://doi.org/10.1093/noajnl/vdaf022
In the originally published version of this manuscript, the author Quincy Okobi’s name was incorrectly given as Qunicy Okobi. This error has been corrected.